Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H11N |
Molecular Weight | 133.1903 |
Optical Activity | ( - ) |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N[C@@H]1CCC2=C1C=CC=C2
InChI
InChIKey=XJEVHMGJSYVQBQ-SECBINFHSA-N
InChI=1S/C9H11N/c10-9-6-5-7-3-1-2-4-8(7)9/h1-4,9H,5-6,10H2/t9-/m1/s1
Molecular Formula | C9H11N |
Molecular Weight | 133.1903 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:52:05 GMT 2023
by
admin
on
Sat Dec 16 10:52:05 GMT 2023
|
Record UNII |
I17RC77CJ2
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
10277-74-4
Created by
admin on Sat Dec 16 10:52:05 GMT 2023 , Edited by admin on Sat Dec 16 10:52:05 GMT 2023
|
PRIMARY | |||
|
2733933
Created by
admin on Sat Dec 16 10:52:05 GMT 2023 , Edited by admin on Sat Dec 16 10:52:05 GMT 2023
|
PRIMARY | |||
|
DTXSID70370045
Created by
admin on Sat Dec 16 10:52:05 GMT 2023 , Edited by admin on Sat Dec 16 10:52:05 GMT 2023
|
PRIMARY | |||
|
I17RC77CJ2
Created by
admin on Sat Dec 16 10:52:05 GMT 2023 , Edited by admin on Sat Dec 16 10:52:05 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
RACEMATE -> ENANTIOMER |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
major metabolite, 1(R)-aminoindan, which is not an MAO inhibitor, has been therapeutically active in animal models relevant to Parkinson?s disease
MAJOR
PLASMA
|